ST638 is a protein tyrosine kinase inhibitor (IC50 = 370 nM) that also inhibits HGF-induced MAP kinase activation in hepatocytes. ST638 has also shown to inhibit PC-PLD (phospholipase D) activity in human neutrophils. This product decreases the O2⋅ production induced by pervanadate in neutrophils.
Adachi, T., et al. 1996. Hepatology 23, 1244. Yamaguchi, M., et al. 1995. Arch. Biochem. Biophys. 323, 382. Uings, I., et al. 1992. Biochem. J. 281, 597. Shiraishi, T., et al. 1988. Chem. Pharm. Bull. 36, 974.